LAVAL, QC – Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE: BHC) (TSX: BHC), announced that its topical prescription treatment for acne vulgaris, PrARAZLOTM (tazarotene lotion, 0.045%… Read More
OTTAWA, ON – The Stem Cell Network (SCN) is pleased to announce the formation of its first-ever Patient Committee. Engaging with patient communities to better understand their needs is vital to… Read More
The UBC Medical Alumni Association (MAA) will be celebrating the achievements of several faculty members and students from the UBC medical community at its upcoming UBC Medical Alumni Celebration &… Read More
VANCOUVER, BC – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, announced five… Read More
UBC Faculty of Medicine researchers are part of a new national network that recently received $20 million in federal funding from the Canadian Institutes of Health Research Rare Disease Research Initiative for… Read More
